Delivery Order SPE2DB22D1106-SPE2DB25FEJN7

Award Date 4/18/25
Potential Completion Date 4/21/25
Potential Value $7.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of Wegovy 0.5 mg/0.5 ml pens, a medication used for the treatment of obesity. The contract has a ceiling value of $4,477.20 and a period of performance through May 8, 2025. It is a firm-fixed price contract, indicating no cost risk to the government. The contract is not designated as a set-aside, meaning it was...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract is for the supply of Wegovy 2.4 mg/0.75 ml pens, a medication used to treat obesity. The contract has a ceiling value of $27,499.49 and a period of performance through April 29, 2025. AmerisourceBergen Drug Corporation holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Wegovy 1.7 mg/0.75 ml pens, a medication used to treat obesity. The contract has a ceiling value of $19,142.22 and a period of performance through May 5, 2025. It is a firm-fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen Drug Corp holds a...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Wegovy 0.5 mg/0.5 ml pens, a medication used for the treatment of obesity. The contract has a ceiling value of $4,914.00 and a performance period ending on May 8, 2025. AmerisourceBergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Wegovy 0.25 mg/0.5 ml pen 0.5 ml, a medication used for the treatment of obesity. The contract has a firm fixed price of $2,730.65 and a period of performance through June 23, 2025. It is not designated as a set-aside contract, indicating open competition. AmerisourceBergen...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Wegovy 1 mg/0.5 mL pens, a medication used to treat obesity. The contract has a ceiling value of $2,726.36 and a period of performance through April 2025. It is a firm-fixed-price contract and is not set aside for any specific business category. AmerisourceBergen Drug Corp holds a substantial...
This is a delivery order federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the supply of Wegovy 0.5 mg/0.5 mL pens, a medication used for weight management. The contract has a ceiling value of $2,457.00 and runs through February 11, 2025. It is a firm fixed-price delivery order contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a larger Indefinite Delivery...
This is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $17,237.02 contract is for the supply of Wegovy 0.5 mg/0.5 ml pens, a prescription medication used to treat obesity. The contract has an ultimate completion date of April 29, 2025. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) between AmerisourceBergen and DLA Troop Support Medical, which...
This is a delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the delivery of Wegovy 1.7 mg/0.75 ml pens, a medication used to treat obesity. The contract has a ceiling value of $2,866.50 and a period of performance through May 8, 2025. Amerisourcebergen Drug Corp is the prime contractor, and the contract is not set aside for any specific business type. The contract is a firm fixed-price...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of Wegovy 2.4 mg/0.75 ml pens, a medication used to treat obesity. The contract has a ceiling value of $2,457.00 and an ultimate completion date of April 11, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp is the prime contractor and holds a larger Indefinite Delivery...
  • SPE2DB22D1106
    Indefinite Delivery Contract
  • SPE2DB22D1106-SPE2DB25FEJN7
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Wegovy 1 mg/0.5 ml pens, a medication used for the treatment of obesity. The contract has a ceiling value of $7,600.89 and a period of performance through April 2025. The contract is a firm fixed-price delivery order, which indicates it is part of a larger Indefinite Delivery Contract (IDC) with DLA. AmerisourceBergen holds a substantial IDC with DLA Troop Support Medical, valued at $999,999,999.00, that provides a comprehensive global pharmaceutical support vehicle through December 2026. This contract allows for multiple delivery orders across different therapeutic categories, positioning AmerisourceBergen as a critical vendor in supporting federal medical procurement needs, particularly for military and veteran healthcare systems. The contract is not designated as a set-aside.

Generated 7/18/25, 9:53 AM